Top Markets
Coin of the day
Nuo Therapeutics, Inc. Nuo Therapeutics, Inc.

Nuo Therapeutics, Inc.

AURX
Clasificación en acciones #25544
Nuo Therapeutics, Inc. operates as a regenerative medicine company,... Nuo Therapeutics, Inc. operates as a regenerative medicine company, specializing in the development, commercialization, and marketing of advanced cell-based technologies. These solutions are engineered to leverage the human body's inherent capacity for natural healing, with a primary focus on the United States market. Central to their offerings is a technology that isolates components from a patient's own blood (autologous) to generate a platelet-based therapy, specifically tailored for the treatment of chronic wounds. Established in Houston, Texas, in 1998, the company underwent a name change from Cytomedix, Inc. to Nuo Therapeutics, Inc. in November 2014.
Precio por acción
$1.00
Última sincronización: 2026-08-19
Capitalización bursátil
$48.41M
Cambio (1 día)
0.00%
Cambio (1 año)
-41.86%
País
US
Comercio Nuo Therapeutics, Inc. (AURX)

Categoría

Ratio P/S de Nuo Therapeutics, Inc. (AURX)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Nuo Therapeutics, Inc., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Nuo Therapeutics, Inc. desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
10.17 -
US
10.13 -
NL
2.95 -
AU
- -
CH
11.28 -
US